Gene therapy targets chronic nerve pain in new trial
Symptom relief
Recruiting now
This study tests a one-time gene therapy called ST-503 for people with hard-to-treat pain from small fiber neuropathy. The therapy aims to block pain signals before they reach the brain. About 27 adults will receive either the gene therapy or a sham procedure to check safety and …
Phase: PHASE1, PHASE2 • Sponsor: Sangamo Therapeutics • Aim: Symptom relief
Last updated May 17, 2026 04:11 UTC